Research
Previously funded studies appear chronologically, with the most recent appearing first.
Receptor Tyrosine Kinase Activity in Canine Hemangiosarcoma
Hemangiosarcoma (HSA) is a common and fatal canine cancer, for which there are no effective treatments. HSA is caused by malignant blood vessel cells that spread. Despite surgery and chemotherapy, the median survival time for dogs diagnosed with HSA is little more than six months. It is more commonly seen in male dogs between eight […]Continue reading